Capital Investment Counsel, Inc Bristol Myers Squibb CO Transaction History

Capital Investment Counsel, Inc

$661 Million
Q4 2024

A detailed history of Capital Investment Counsel, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 5,124 shares of BMY stock, worth $291,299. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,124

Previous 5,279 2.94%

Holding current value

$291,299

Previous $273,000 5.86%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$51.92 - $59.94 $8,047 - $9,290	-155 Reduced 2.94%	5,124 $289,000
Q3 2024 Oct 22, 2024	BUY	$39.66 - $51.75 $2,181 - $2,846	55 Added 1.05%	5,279 $273,000
Q2 2024 Jul 22, 2024	BUY	$40.25 - $52.99 $2,737 - $3,603	68 Added 1.32%	5,224 $216,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $4,845 - $5,494	-101 Reduced 1.92%	5,156 $279,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $16,968 - $20,247	-350 Reduced 6.24%	5,257 $269,000
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $6,434 - $7,144	101 Added 1.83%	5,607 $358,000
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $86,010 - $101,849	1,256 Added 29.55%	5,506 $396,000
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $228 - $134,931	-1,756 Reduced 29.24%	4,250 $302,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $123,454 - $135,966	-1,700 Reduced 22.06%	6,006 $462,000
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $9,222 - $11,058	-150 Reduced 1.91%	7,706 $563,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $21,452 - $25,008	-400 Reduced 4.84%	7,856 $490,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $44,377 - $51,982	-750 Reduced 8.33%	8,256 $489,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $139,805 - $157,239	2,356 Added 35.43%	9,006 $569,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $136,035 - $154,153	-2,356 Reduced 26.16%	6,650 $412,000
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $135,305 - $149,935	2,356 Added 35.43%	9,006 $543,000
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $129,155 - $150,996	-2,356 Reduced 26.16%	6,650 $391,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $40,228 - $58,461	-867 Reduced 8.78%	9,006 $502,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $27,902 - $36,395	567 Added 6.09%	9,873 $634,000
Q2 2019 Jul 26, 2019	BUY	$44.62 - $49.34 $140,553 - $155,421	3,150 Added 51.17%	9,306 $422,000
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $9,752 - $12,646	200 Added 3.36%	6,156 $320,000
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $82,785 - $93,375	-1,500 Reduced 20.12%	5,956 $370,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $202,120 - $251,920	4,000 Added 115.74%	7,456 $413,000
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $23,976 - $26,139	-400 Reduced 10.37%	3,456 $212,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $212,966 - $245,781	3,856	3,856 $246,000

Others Institutions Holding BMY

# of Institutions

2,639

Shares Held

1.46B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.

Account

Capital Investment Counsel, Inc Bristol Myers Squibb CO Transaction History